RxDoctor Payments Data

Supriya Narang, MD

Psychiatry · Timonium, MDNPI 1083689293

Payments from drug & device makers

$4,723in general payments, 2019–2025

Across 278 payments — averaging $16.99 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Otsuka America Pharmaceutical, Inc.$720
  • Johnson & Johnson$651
  • AbbVie$620
  • Alkermes, Inc.$444
  • Teva Pharmaceuticals USA, Inc.$411
  • Lundbeck LLC$370
  • plus $2K from 14 others

What the payments were for

  • Food & beverage$4,66699%
  • Education$571%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$4,723 in reported general payments places this provider in the 90th percentile of 851 psychiatry providers in Maryland.

See all psychiatry providers in Maryland

Medicare billing

Part B allowed, 2024
$72,040
Medicare patients
134
Services billed
663

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
AustedoDeutetrabenazine20$131,846
Invega SustennaPaliperidone Palmitate40$131,455
Abilify MaintenaAripiprazole18$52,515
VraylarCariprazine Hcl28$43,314
Risperdal ConstaRisperidone Microspheres17$38,098
Aripiprazole105$34,242
Clozapine316$22,079
LybalviOlanzapine/Samidorphan Malate12$19,581
Lurasidone Hcl63$19,223
Fluphenazine Hcl53$13,804
Paliperidone ErPaliperidone32$11,433
Chlorpromazine Hcl36$8,123
Asenapine Maleate18$7,034
Ziprasidone Hcl39$6,861
Risperidone OdtRisperidone51$6,840

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Johnson & JohnsonInvega Sustenna, Risperdal Consta$651$169,55457 claims
Teva Pharmaceuticals USA, Inc.Austedo$411$131,84620 claims
Otsuka America Pharmaceutical, Inc.Abilify Maintena$720$52,51518 claims
AbbVieVraylar$620$43,31428 claims
Alkermes, Inc.Lybalvi$444$19,58112 claims
Takeda Pharmaceuticals U.S.A., Inc.Trintellix$58$6,54914 claims
Almatica Pharma LLCSertraline Hcl$73$1,698189 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 851 psychiatry providers in Maryland.

Other psychiatry in Timonium

See the full list for Maryland

Where these figures come from

Is this you, or does something look wrong? →